Home LiteratureArticle Details
PMID: 11805289 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Human macrophage activation programs induced by bacterial pathogens.

Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, Young RA

Abstract

Understanding the response of innate immune cells to pathogens may provide insights to host defenses and the tactics used by pathogens to circumvent these defenses. We used DNA microarrays to explore the responses of human macrophages to a variety of bacteria. Macrophages responded to a broad range of bacteria with a robust, shared pattern of gene expression. The shared response includes genes encoding receptors, signal transduction molecules, and transcription factors. This shared activation program transforms the macrophage into a cell primed to interact with its environment and to mount an immune response. Further study revealed that the activation program is induced by bacterial components that are Toll-like receptor agonists, including lipopolysaccharide, lipoteichoic acid, muramyl dipeptide, and heat shock proteins. Pathogen-specific responses were also apparent in the macrophage expression profiles. Analysis of Mycobacterium tuberculosis-specific responses revealed inhibition of interleukin-12 production, suggesting one means by which this organism survives host defenses. These results improve our understanding of macrophage defenses, provide insights into mechanisms of pathogenesis, and suggest targets for therapeutic intervention.

MeSH Terms
Acetylmuramyl-Alanyl-Isoglutamine/pharmacology Cells, Cultured DNA, Complementary/genetics Gram-Negative Bacteria/immunology Gram-Positive Bacteria/immunology Heat-Shock Proteins/pharmacology Humans Lipopolysaccharides/pharmacology Macrophage Activation/drug effects,immunology Macrophages/drug effects,immunology,microbiology Mycobacterium/immunology Nucleic Acid Hybridization Oligonucleotide Array Sequence Analysis Teichoic Acids/pharmacology
Chemicals
DNA, Complementary Heat-Shock Proteins Lipopolysaccharides Teichoic Acids Acetylmuramyl-Alanyl-Isoglutamine lipoteichoic acid
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Nau Gerard J
Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142, USA.
Richmond Joan F L
Schlesinger Ann
Jennings Ezra G
Lander Eric S
Young Richard A
References (30)
30 references, click to expand
  1. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.
    J Immunol. 2000 Jan 15;164(2):558-61 PMID: 10623794
  2. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
    J Immunol. 1999 Jul 1;163(1):1-5 PMID: 10384090
  3. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
    J Clin Invest. 2000 Feb;105(4):497-504 PMID: 10683379
  4. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus.
    Trends Microbiol. 2000 Mar;8(3):111-9 PMID: 10707064
  5. Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice.
    Infect Immun. 2000 May;68(5):2962-70 PMID: 10768995
  6. Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7.
    Cell Stress Chaperones. 2000 Nov;5(5):401-5 PMID: 11189443
  7. Evasion of host cell defense mechanisms by pathogenic bacteria.
    Curr Opin Immunol. 2001 Feb;13(1):37-44 PMID: 11154915
  8. Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro.
    Infect Immun. 2001 Mar;69(3):1433-9 PMID: 11179309
  9. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response.
    J Immunol. 2001 Jun 15;166(12):7033-41 PMID: 11390447
  10. Toll-like receptors: critical proteins linking innate and acquired immunity.
    Nat Immunol. 2001 Aug;2(8):675-80 PMID: 11477402
  11. Pathogenic trickery: deception of host cell processes.
    Nat Rev Mol Cell Biol. 2001 Aug;2(8):578-88 PMID: 11483991
  12. Interleukin-12 as successful adjuvant in tuberculosis treatment.
    Eur Respir J. 2001 May;17(5):1049-51 PMID: 11488308
  13. Functional transitions in macrophages during in vivo infection with Mycobacterium bovis bacillus Calmette-Guérin.
    J Immunol. 2001 Aug 15;167(4):2227-33 PMID: 11490009
  14. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells.
    J Biol Chem. 2001 Aug 17;276(33):31332-9 PMID: 11402040
  15. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.
    J Immunol. 1995 Sep 1;155(5):2515-24 PMID: 7650381
  16. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.
    J Exp Med. 1996 Feb 1;183(2):515-26 PMID: 8627163
  17. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.
    Immunity. 1996 May;4(5):471-81 PMID: 8630732
  18. Regulation of interleukin-12 by complement receptor 3 signaling.
    J Exp Med. 1997 Jun 2;185(11):1987-95 PMID: 9166428
  19. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis.
    Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6414-9 PMID: 9177232
  20. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.
    J Exp Med. 1997 Jul 7;186(1):39-45 PMID: 9206995
  21. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice.
    J Immunol. 1998 Jun 1;160(11):5428-35 PMID: 9605144
  22. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
    Science. 1998 May 29;280(5368):1432-5 PMID: 9603732
  23. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients.
    Science. 1998 May 29;280(5368):1435-8 PMID: 9603733
  24. Expression monitoring by hybridization to high-density oligonucleotide arrays.
    Nat Biotechnol. 1996 Dec;14(13):1675-80 PMID: 9634850
  25. Cluster analysis and display of genome-wide expression patterns.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 PMID: 9843981
  26. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
    Science. 1998 Dec 11;282(5396):2085-8 PMID: 9851930
  27. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.
    J Clin Invest. 1998 Dec 15;102(12):2035-40 PMID: 9854038
  28. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction.
    J Biol Chem. 1999 Apr 16;274(16):10689-92 PMID: 10196138
  29. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.
    J Biol Chem. 1999 Jun 18;274(25):17406-9 PMID: 10364168
  30. Cytokine therapy of mycobacterial infections.
    Adv Intern Med. 2000;45:431-52 PMID: 10635058
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2002-02-05
Epub
2002-00-22
Pages
1503-8
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC122220
Subset
IM
Grants
NIAID NIH HHS · AI-753230 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]